22148-82-9 Usage
Neuroprotective effects
MP4A has been investigated for its potential to protect neurons from damage and prevent neurodegeneration.
Role in preventing neurodegeneration
MP4A may help slow down or prevent the progression of neurodegenerative disorders, such as Parkinson's disease, by protecting neurons and maintaining neurotransmitter levels.
Ongoing research
The study of 1-Methyl-4-phenyl-butylamine is still in progress, with researchers working to better understand its potential benefits and applications in treating neurodegenerative disorders.
Value in understanding and treating neurodegenerative disorders
MP4A has the potential to be a valuable tool in the research and treatment of conditions like Parkinson's disease, as it targets a specific enzyme and has demonstrated neuroprotective properties.
Check Digit Verification of cas no
The CAS Registry Mumber 22148-82-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,1,4 and 8 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 22148-82:
(7*2)+(6*2)+(5*1)+(4*4)+(3*8)+(2*8)+(1*2)=89
89 % 10 = 9
So 22148-82-9 is a valid CAS Registry Number.
22148-82-9Relevant articles and documents
Straightforward access to α-methylamines through cross-metathesis
Poulhes, Florent,Sylvain, Remy,Perfetti, Patricia,Bertrand, Michele P.,Gil, Gerard,Gastaldi, Stephane
experimental part, p. 1334 - 1338 (2010/07/06)
A two-step procedure involving cross-metathesis and reductive amination enables easy access to -methylamines and α,α′-dimethyldiamines from a wide variety of terminal olefins. Georg Thieme Verlag Stuttgart · New York.
Enantioselective synthesis of α,α-disubstituted amines from nitroalkenes
Leroux, Mary-Lorene,Le Gall, Thierry,Mioskowski, Charles
, p. 1817 - 1823 (2007/10/03)
Disubstituted nitroalkenes were converted into enantiomerically enriched amines (isolated as their hydrochloride salts) with enantiometric excesses of 88 to >95% in there steps: (a) highly stereoselective conjugate addition of the potassium salt of 4-phenyloxazolidin-2-one; (b) radical-mediated removal of the nitro group; (c) cleavage of the oxazolidinone.
